MedTrace Logo

Validation of Sensitivity and Specificity of a Multi-Omic Precision Diagnostic for Acute Stroke Evaluation

NCT02753257 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-04-04

No results posted yet for this study

Summary

Valtari Bio has early proof of concept clinical data of a multi-omic peripheral blood biomarker profile that can be used to determine stroke from no stroke in the emergency setting. The objective of this observational cohort clinical study is to determine the clinical utility of this multi-omic biomarker profile.

Primary Study Aims:

1. The diagnostic tests characteristics of a multi-omic biomarker diagnostic for stroke (ischemic stroke, transient ischemic attack (TIA) and hemorrhagic stroke) versus no stroke (stroke mimic).
2. The ability of a multi-omic biomarker profile to differentiate ischemic stroke from hemorrhagic stroke and TIA.

Conditions

Interventions

OTHER

Non-Interventional

Non-Interventional

Sponsors & Collaborators

  • University of Cincinnati

    collaborator OTHER

  • University of Texas at Austin

    collaborator OTHER

  • Valtari Bio

    lead INDUSTRY

Principal Investigators

  • Taura L Barr, PhD RN · Valtari Bio

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02753257 on ClinicalTrials.gov